Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DRI Ecstasy Plus Assay

K-Number: K240670 · 2024-10-30

Decision Date2024-10-30
Product CodeDKZ
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

DRI Ecstasy Plus Assay is the device name listed in this FDA 510(k) record. The listed applicant is Microgenics Corporation. It received FDA 510(k) clearance on 2024-10-30 under 510(k) number K240670. The device is classified under product code DKZ. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DRI Ecstasy Plus Assay?

DRI Ecstasy Plus Assay is a medical device that received FDA 510(k) clearance on 2024-10-30. The listed applicant is Microgenics Corporation. The 510(k) number is K240670.

When did DRI Ecstasy Plus Assay receive FDA 510(k) clearance?

DRI Ecstasy Plus Assay received FDA 510(k) clearance on 2024-10-30, under 510(k) number K240670.

Who is the listed applicant for DRI Ecstasy Plus Assay?

The FDA 510(k) record lists Microgenics Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for DRI Ecstasy Plus Assay?

The FDA product code for DRI Ecstasy Plus Assay is DKZ.

Other records listing Microgenics Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 13 devices →

Related Devices (Code: DKZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.